Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown 9 Meters Biopharma Inc. NMTR

9 Meters Biopharma Inc is a clinical-stage biopharmaceutical company focused on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. Its products include NM-002, Larazotide, NM-003 and others.


Top institutional share ownership of 9 Meters Biopharma Inc

Name Shares Shares % change Value Value % change
Adage Capital Partners Gp, L.l.c. 13,000,000 -9.1% $2,795 -25.0%
Vanguard Group Inc 12,561,009 9.2% $2,700 -10.0%
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 8,912,940 11.0% $1,916 -8.5%
Laurion Capital Management LP 4,558,200 0.1% $980 -17.4%
BlackRock Inc. 3,367,429 -0.1% $724 -17.7%
VEXMX - Vanguard Extended Market Index Fund Investor Shares 3,218,460 5.9% $692 -12.8%
Gsa Capital Partners Llp 2,348,287 400.5% $505 313.9%
Geode Capital Management, Llc 2,312,696 0.0% $497 -17.6%
Renaissance Technologies Llc 1,662,200 254.2% $357 192.6%
FSMAX - Fidelity Extended Market Index Fund 1,231,676 -1.2% $327 -42.1%

Top institutional buyers of 9 Meters Biopharma Inc

Name Shares % change Value % change Shares Value
Two Sigma Investments, Lp 7611.8% 6066.7% 860,403 $185
Gsa Capital Partners Llp 400.5% 313.9% 2,348,287 $505
Renaissance Technologies Llc 254.2% 192.6% 1,662,200 $357
Commonwealth Equity Services, Llc 35.9% 12.0% 394,592 $84
Virtu Financial LLC 25.6% 4.3% 228,595 $49
FCFMX - Fidelity Series Total Market Index Fund 20.3% -29.7% 295,999 $78
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 11.0% -8.5% 8,912,940 $1,916
Vanguard Group Inc 9.2% -10.0% 12,561,009 $2,700
VEXMX - Vanguard Extended Market Index Fund Investor Shares 5.9% -12.8% 3,218,460 $692
Valeo Financial Advisors, LLC 5.8% -13.5% 209,688 $45

Top institutional sellers of 9 Meters Biopharma Inc

Name Shares % change Value % change Shares Value
Millennium Management Llc -48.2% -57.4% 958,880 $206
Qube Research & Technologies Ltd -18.2% -32.0% 235,334 $51
Adage Capital Partners Gp, L.l.c. -9.1% -25.0% 13,000,000 $2,795
Ergoteles LLC -8.5% -24.6% 911,451 $196
Group One Trading, L.p. -7.7% -24.1% 191,138 $41
Northern Trust Corp -2.2% -19.7% 440,081 $94
FSMAX - Fidelity Extended Market Index Fund -1.2% -42.1% 1,231,676 $327
BlackRock Inc. -0.1% -17.7% 3,367,429 $724

Information provided by Fintel.io